全文获取类型
收费全文 | 6272篇 |
免费 | 215篇 |
国内免费 | 154篇 |
出版年
2023年 | 41篇 |
2022年 | 92篇 |
2021年 | 128篇 |
2020年 | 137篇 |
2019年 | 179篇 |
2018年 | 183篇 |
2017年 | 124篇 |
2016年 | 134篇 |
2015年 | 152篇 |
2014年 | 423篇 |
2013年 | 459篇 |
2012年 | 352篇 |
2011年 | 501篇 |
2010年 | 384篇 |
2009年 | 281篇 |
2008年 | 294篇 |
2007年 | 290篇 |
2006年 | 269篇 |
2005年 | 238篇 |
2004年 | 200篇 |
2003年 | 165篇 |
2002年 | 117篇 |
2001年 | 80篇 |
2000年 | 64篇 |
1999年 | 77篇 |
1998年 | 60篇 |
1997年 | 68篇 |
1996年 | 69篇 |
1995年 | 62篇 |
1994年 | 73篇 |
1993年 | 82篇 |
1992年 | 60篇 |
1991年 | 67篇 |
1990年 | 70篇 |
1989年 | 50篇 |
1988年 | 53篇 |
1987年 | 45篇 |
1986年 | 31篇 |
1985年 | 38篇 |
1984年 | 62篇 |
1983年 | 48篇 |
1982年 | 69篇 |
1981年 | 46篇 |
1980年 | 49篇 |
1979年 | 28篇 |
1978年 | 27篇 |
1977年 | 22篇 |
1976年 | 16篇 |
1974年 | 12篇 |
1973年 | 24篇 |
排序方式: 共有6641条查询结果,搜索用时 15 毫秒
1.
《Nucleosides, nucleotides & nucleic acids》2013,32(5-8):837-839
Abstract Some diacid biodegradable synthesis of aziduthymidine (AZT) were synthesized and applied to production of about 60 different derivatives. 相似文献
2.
3.
The vascular system is critical for developmental growth, tissue homeostasis and repair but also for tumor development. Bone morphogenetic protein (BMP) signaling has recently emerged as a fundamental pathway of the endothelium by regulating cardiovascular and lymphatic development and by being causative for several vascular dysfunctions. Two vascular disorders have been directly linked to impaired BMP signaling: pulmonary arterial hypertension and hereditary hemorrhagic telangiectasia. Endothelial BMP signaling critically depends on the cellular context, which includes among others vascular heterogeneity, exposure to flow, and the intertwining with other signaling cascades (Notch, WNT, Hippo and hypoxia). The purpose of this review is to highlight the most recent findings illustrating the clear need for reconsidering the role of BMPs in vascular biology. 相似文献
4.
Ruth Duncan Pavla Rejmanova Jindrich Kopeček John B. Lloyd 《Biochimica et Biophysica Acta (BBA)/General Subjects》1981,678(1):143-150
Synthetic 125I-labelled N-(2-hydroxypropyl)methacrylamide copolymers containing four different, potentially degradable peptidyl side chains were incubated with rat visceral yolk sacs cultured in vitro. All copolymers were captured by fluid-phase pinocytosis and three of the side chains were susceptible to lysosomal hydrolysis, resulting in release of [125I]iodotyrosine back into the culture medium. Uptake and degradation was completely inhibited by 2,4-dinitrophenol. The thiol-proteinase inhibitor leupeptin did not affect the rate of pinocytosis, but caused different degrees of inhibition of hydrolysis depending on side chain composition. 相似文献
5.
Reactive oxygen species (ROS) are involved in the pathophysiology of fulminant hepatic failure. Therefore, we developed polyethylene glycol-conjugated bovine serum albumin with multiple reduced thiols (PEG-BSA-SH) for the treatment of fulminant hepatic failure. As a long-circulating ROS scavenger, PEG-BSA-SH effectively scavenged highly reactive oxygen species and hydrogen peroxide in buffer solution. PEG-BSA-SH showed a long circulation time in the plasma after intravenous injection into mice. Fulminant hepatic failure was induced by intraperitoneal injection of lipopolysaccharide and d-galactosamine (LPS/d-GalN) into mice. The LPS/d-GalN-induced elevation of plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels was significantly inhibited by a bolus intravenous injection of PEG-BSA-SH. Furthermore, the changes in hepatic lipid peroxide and hepatic blood flow were effectively suppressed by PEG-BSA-SH. In contrast, l-cysteine, glutathione, and dithiothreitol, three traditional reduced thiols, had no statistically significant effects on the serum levels of ALT or AST. These findings indicate that PEG-BSA-SH is a promising ROS scavenger and useful in the treatment of fulminant hepatic failure. 相似文献
6.
7.
Lars Terenius Björn Johansson 《Biochemical and biophysical research communications》2010,396(1):140-142
This mini-review outlines the opioid systems and their roles primarily as related to reward and compulsive drug/alcohol intake. The central role is taken by the mu-opioid receptor, target for opiate analgesics and also a central target in compulsive alcohol abuse, alcoholism. The mu-opioid receptor and the cognate opioid neuropeptides from proenkephalin and proopiomelancortin are members of a superfamily of opioid systems, each with unique and still to be defined roles in the central nervous system. 相似文献
8.
Developmental patterns of galactosyltransferase activity in various regions of rat brain 总被引:2,自引:1,他引:1
Abstract: The developmental pattern of glycoprotein-galactosyltransferase activity was determined in the microsomal fractions of three regions of the embryonic rat brain and in parts of the visual system and the cerebellum postnatally. It could be shown that the enzyme activity was highest in the embryonic brain, where regional differences were apparent, and decreased progressively after birth. The enzyme profile in the cerebellum showed no marked postnatal changes. 相似文献
9.
Changsung Kim 《BMB reports》2015,48(5):256-265
Cardiovascular and neurodegenerative diseases are major health threats in many
developed countries. Recently, target tissues derived from human embryonic stem
(hES) cells and induced pluripotent stem cells (iPSCs), such as cardiomyocytes
(CMs) or neurons, have been actively mobilized for drug screening. Knowledge of
drug toxicity and efficacy obtained using stem cell-derived tissues could
parallel that obtained from human trials. Furthermore, iPSC disease models could
be advantageous in the development of personalized medicine in various parts of
disease sectors. To obtain the maximum benefit from iPSCs in disease modeling,
researchers are now focusing on aging, maturation, and metabolism to
recapitulate the pathological features seen in patients. Compared to pediatric
disease modeling, adult-onset disease modeling with iPSCs requires proper
maturation for full manifestation of pathological features. Herein, the success
of iPSC technology, focusing on patient-specific drug treatment,
maturation-based disease modeling, and alternative approaches to compensate for
the current limitations of patient iPSC modeling, will be further discussed.
[BMB Reports 2015; 48(5): 256-265] 相似文献
10.